1.Subcutaneous mycosis presenting as a non- healing left calf ulcer in an immunocompromised patient
Andy Tang Sing Ong ; Dr Yong Kar Ying ; Dr Jacqueline Wong Oy Leng ; Chua Hock Hin ; Chew Lee Ping
The Medical Journal of Malaysia 2017;72(2):122-123
This is a case report of subcutaneous mycosis presenting
as a non-healing left calf ulcer in an immunocompromised
patient. Traumatic inoculation of the causative agent is the
most likely route of infection. The diagnosis requires a
detailed history and high clinical suspicion, confirmed by
histopathological examination. The management requires a
multidisciplinary team approach involving surgeon,
pathologist, physician sub-specialised in infectious disease,
wound care nursing team as well as social support services.
The literature review recommended that the treatment of
choice for such infection is surgical debridement in addition
to optimal antifungal therapy.
Mycoses
2.The use of traditional Chinese medicine among breast cancer patients: implications for the clinician.
Kar Yong WONG ; Ern Yu TAN ; Juliana J C CHEN ; Christine TEO ; Patrick M Y CHAN
Annals of the Academy of Medicine, Singapore 2014;43(2):74-78
INTRODUCTIONTraditional Chinese Medicine or Traditional Complementary Medicine (TCM) is commonly used in our culture. There are several concerns regarding its use in patients undergoing conventional treatments for breast cancer. In this study, we aimed to evaluate the prevalence and pattern of TCM use among our breast cancer patients, and to identify patients who were most likely to choose TCM.
MATERIALS AND METHODSA total of 300 patients on active follow-up with Breast Service at Tan Tock Seng Hospital were interviewed using a structured questionnaire.
RESULTSA total of 35% (104 of 296) of patients reported using TCM. The majority of the patients were introduced to TCM by family and friends following the diagnosis of breast cancer. All except 3 patients continued with recommended conventional therapy although most did not inform their clinicians of TCM use. None of the patients reported any serious adverse events and 75% of them perceived a benefit from TCM use. Younger patients and those of Chinese ethnicity were more likely to use TCM (P <0.01 and P = 0.03 respectively). There was no significant difference in the dialect group, religious beliefs and educational level between the 2 groups (P >0.05).
CONCLUSIONTCM use is common among our breast cancer patients, particularly the younger women. However, most patients do not inform their clinicians of TCM use while on recommended conventional therapies. It is therefore important for clinicians to initiate discussions regarding TCM use in order to be aware of potential unwanted drug interactions.
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms ; therapy ; Female ; Humans ; Medical Oncology ; Medicine, Chinese Traditional ; utilization ; Middle Aged
3.Barriers to implementing a national health screening program for men in Malaysia: An online survey of healthcare providers
Chirk Jenn Ng ; Chin Hai Teo ; Kar Mun Ang ; Yong Leng Kok ; Khalid Ashraf ; Hui Ling Leong ; Sri Wahyu Taher ; Zakiah Mohd Said ; Zainal Fitri Zakaria ; Ping Foo Wong ; Chee Peng Hor ; Teng Aik Ong ; Husni Hussain ; V Paranthaman P Vengadasalam ; Chiu Wan Ng ; Kavitha Agamutu ; Mohamad Aznuddin Abd Razak
Malaysian Family Physician 2020;15(1):6-14
Introduction: This study aimed to determine the views and practices of healthcare providers and
barriers they encountered when implementing the national health screening program for men in a
public primary care setting in Malaysia.
Methods: An online survey was conducted among healthcare providers across public health clinics in
Malaysia. All family medicine specialists, medical officers, nurses and assistant medical officers involved in the screening program for adult men were invited to answer a 51-item questionnaire via email or WhatsApp. The questionnaire comprised five sections: participants’ socio-demographic information, current screening practices, barriers and facilitators to using the screening tool, and views on the content and format of the screening tool.
Results: A total of 231 healthcare providers from 129 health clinics participated in this survey.
Among them, 37.44% perceived the implementation of the screening program as a “top-down
decision.” Although 37.44% found the screening tool for adult men “useful,” some felt that it was
“time consuming” to fill out (38.2%) and “lengthy” (28.3%). In addition, ‘adult men refuse to answer’
(24.1%) was cited as the most common patient-related barrier.
Conclusions: This study provided useful insights into the challenges encountered by the public
healthcare providers when implementing a national screening program for men. The screening tool for
adult men should be revised to make it more user-friendly. Further studies should explore the reasons
why men were reluctant to participate in health screenings, thus enhancing the implementation of
screening programs in primary care.
4.Anti-migratory effects of Piper betle leaf aqueous extract on cancer cells and its microtubule targeting properties.
Mee Lee LOOI ; Alwyn Khai Howe WONG ; Shelly Anne GNAPRAGASAN ; Anis Zafirah JAPRI ; Aiysvariyah RAJEDADRAM ; Kar Yong PIN
Journal of Zhejiang University. Science. B 2020;21(9):745-748
Piper betle (PB), also known as "betel" in Malay language, is a tropical Asian vine. PB leaves are commonly chewed by Asians along with betel quid. It contains phenols such as eugenol and hydroxychavicol along with chlorophyll, β-carotene, and vitamin C (Salehi et al., 2019). Extracts from PB leaves have various medicinal properties including anticancer, antioxidant, anti-inflammatory, and antibacterial effects (Salehi et al., 2019). Previous research has shown that PB induces cell cycle arrest at late S or G2/M phase and causes apoptosis at higher doses (Wu et al., 2014; Guha Majumdar and Subramanian, 2019). A combination of PB leaf extract has also been shown to enhance the cytotoxicity of the anticancer drug, 5-fluorouracil (5-FU), in cancer cells (Ng et al., 2014).
Antineoplastic Agents, Phytogenic/pharmacology*
;
Cell Movement/drug effects*
;
HT29 Cells
;
Humans
;
Microtubules/drug effects*
;
Piper betle
;
Plant Extracts/pharmacology*
;
Plant Leaves